Published in Medical Devices and Surgical Technology Week, January 1st, 2006
"Peptide receptor imaging with 111Indium pentetreotide is useful in the diagnosis of diffuse neuroendocrine system tumors (DNEST) of the head and neck," scientists in New York explained. "Uses of 111Indium pentetreotide scintigraphy include tumor and metastases detection, familial tumor screening, and surveillance for recurrence."
"Using target to background ratios (TBR) could generate a comparative scale for these tumors," argued D. Myssiorek and colleagues at the Albert Einstein College of Medicine. In a "retrospective study,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.